Transfection with the cDNA of the human thyrotropin receptor of a poorly differentiated rat thyroid cell line (FRT)

被引:4
|
作者
Elisei, R [1 ]
Pinchera, A [1 ]
Chiovato, L [1 ]
Mammoli, C [1 ]
Agretti, P [1 ]
Romei, C [1 ]
Santini, F [1 ]
Bendinelli, G [1 ]
Fiore, E [1 ]
Capaccioli, A [1 ]
Vitti, P [1 ]
机构
[1] UNIV PISA,IST ENDOCRINOL,I-56018 TIRRENIA,PISA,ITALY
关键词
thyroid cells; transfection; TSH receptor;
D O I
10.1007/BF03349873
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A cell line derived from the Fisher rat thyroid (FRT), that does not have functional TSH receptor, was stably transfected with the cDNA of the human TSH receptor (hTSH-R). In wild FRT cells TSH (1-1000 mU/l) was unable to increase cAMP production, while 10-10000 nmol/l forskolin elicited a 10-30 fold cAMP stimulation. Two of the transfected clones were responsive to TSH in terms of cAMP production. In particular, the FRT-R3 transfected clone showed the highest sensitivity to the hormone with a 10 fold cAMP increase over the basal at 100 mU/l TSH, The Northern blot analysis using a 2.4 kbp cDNA probe for the hTSH-R showed a band correspending to the mRNA of TSH receptor in FRT-R3 cells, but not in wild FRT cells. In both cell types TSH was ineffective in stimulating growth assayed by H-3-thymidine incorporation into DNA. Hybridization with a probe for thyroperoxidase on polymerase chain reaction products after reverse transcription of mRNA showed that FRT-R3, as well as FRT cells, do not have a transcript for thyroperoxidase. In conclusion, the data reported in this paper show that the insertion of the hTSH-R cDNA in the genome of poorly differentiated rat thyroid cells results in the recovery of TSH-dependent adenylate cyclase, but not other differentiated thyroid cell functions.
引用
收藏
页码:230 / 235
页数:6
相关论文
共 50 条
  • [31] High-efficient Nonviral Transfection of the Rat Thyroid Cell Line FRTL-5
    Klagge, A.
    Krause, K.
    Mueller, K.
    Haag, J.
    Fuhrer, D.
    HORMONE AND METABOLIC RESEARCH, 2010, 42 (12) : 897 - 899
  • [32] EXPRESSION OF GALECTIN-1 IN NORMAL HUMAN THYROID-GLAND AND IN DIFFERENTIATED AND POORLY DIFFERENTIATED THYROID-TUMORS
    CHIARIOTTI, L
    BERLINGIERI, MT
    BATTAGLIA, C
    BENVENUTO, G
    MARTELLI, ML
    SALVATORE, P
    CHIAPPETTA, G
    BRUNI, CB
    FUSCO, A
    INTERNATIONAL JOURNAL OF CANCER, 1995, 64 (03) : 171 - 175
  • [33] Functional expression of thyrotropin receptor in differentiated 3T3-L1 cells: A possible model cell line of extrathyroidal expression of thyrotropin receptor
    Haraguchi, K
    Shimura, H
    Lin, L
    Saito, T
    Endo, T
    Onaya, T
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 223 (01) : 193 - 198
  • [34] Recombinant Human Thyrotropin for Management of Metastatic Differentiated Thyroid Carcinoma in Patients With Deficient Reserve of Endogenous Thyrotropin
    Basu, A.
    Abu-Lebdeh, H. S.
    Erickson, D.
    Bahn, R. S.
    Hay, I. D.
    Fatourechi, V
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2005, 3 (03) : 130 - 135
  • [35] TRANSFECTION OF THE HUMAN MUC-1 MUCIN GENE INTO A POORLY DIFFERENTIATED HUMAN PANCREATIC TUMOR-CELL LINE, PANC-1 - INTEGRATION, EXPRESSION AND ULTRASTRUCTURAL-CHANGES
    BATRA, SK
    KERN, HF
    WORLOCK, AJ
    METZGAR, RS
    HOLLINGSWORTH, MA
    JOURNAL OF CELL SCIENCE, 1991, 100 : 841 - &
  • [36] MALIGNANT TRANSFORMATION OF RAT-THYROID CELLS TRANSFECTED WITH THE HUMAN TSH RECEPTOR CDNA
    DERWAHL, M
    BROECKER, M
    AESCHIMANN, S
    SCHATZ, H
    STUDER, H
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 183 (01) : 220 - 226
  • [37] Inhibitory effects of antisense cathepsin B cDNA transfection on invasion and motility in a human osteosarcoma cell line
    Kruger, S
    Haeckel, C
    Buehling, F
    Roessner, A
    CANCER RESEARCH, 1999, 59 (23) : 6010 - 6014
  • [38] THE ROLE OF RECOMBINANT HUMAN THYROTROPIN FOR DIAGNOSTIC MONITORING OF PATIENTS WITH DIFFERENTIATED THYROID CANCER
    Sherman, Steven I.
    ENDOCRINE PRACTICE, 2013, 19 (01) : 157 - 161
  • [39] Recombinant human thyrotropin (TSH) in the management of patients with differentiated thyroid cancer.
    McDougall, IR
    Weigel, RJ
    JOURNAL OF NUCLEAR MEDICINE, 2002, 43 (05) : 323P - 323P
  • [40] Recombinant human thyrotropin in follow-up of patients with differentiated thyroid cancer
    Podoba, J.
    BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2010, 111 (01): : 38 - 40